| Financial Year |
March 31 2023 |
| Monetary Funds |
3,093,204,326.66 |
| Held-for-trading Financial Assets |
1,579,456,308.81 |
| Notes Receivable |
542,298,096.84 |
| Accounts Receivable |
940,745,028.59 |
| Advances to Suppliers |
87,666,700.60 |
| Other Receivables |
9,190,172.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
300,336,387.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
192,858,831.53 |
| Total Current Assets |
6,833,976,811.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,968,885.13 |
| Investment Properties |
-- |
| Fixed Assetes |
3,624,484,920.00 |
| Under-construction Projects |
2,068,493,514.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
596,936,127.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
34,646,715.30 |
| Other Non-Current Assets |
956,369,215.61 |
| Sub-Total of Non-Current Assets |
7,387,284,062.64 |
| Total Assets |
14,221,260,874.13 |
| Short-Term Loans |
755,186,651.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
495,376,657.97 |
| Accounts Payable |
455,416,045.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,779,994.14 |
| Taxes Payable |
42,718,019.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,174,919.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
295,182,387.71 |
| Other Current Liabilities |
2,003,770.07 |
| Sub-Total of Current Liabilities |
2,168,678,761.66 |
| Long-term Loans |
2,694,950,295.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
191,067,655.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,195,394.99 |
| Deferred Income Tax Liabilities |
45,295,058.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,274,586,274.65 |
| Total Liabilities |
5,443,265,036.31 |
| Paid-In Capital(Or Share Stock) |
1,281,727,020.00 |
| Capital Surplus |
5,682,306,370.14 |
| Surplus Reserve |
97,712,536.88 |
| LESS:Treasury Stock |
111,366,256.20 |
| Undistributed Profits |
1,677,684,999.82 |
| Minority Stockholder's Interest |
152,427,157.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,625,568,680.65 |
| Owner's Equity（Stockholder's Equity） |
8,777,995,837.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,221,260,874.13 |
